Treatment of PAP most commonly consists of whole-lung lavage (WLL) and in autoimmune PAP, granulocyte-macrophage colony stimulating factor (GM-CSF) administration. This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.